We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Fast Diagnostic Tool Investigated for Wound Infections

By LabMedica International staff writers
Posted on 29 Aug 2011
A novel concept for a fast diagnostic tool for wound infection based on enzymes triggered release of dye from a polymeric matrix has been investigated.

For the development of a simple diagnostic tool, a liquid lysozyme assay was adapted to a solid system and the matrix consisted of alginate/agarose and peptidoglycan covalently labeled with Remazol brilliant blue. More...


Scientists from the Graz University of Technology (Austria) collected wound fluid from 10 postoperative wounds, 8 decubitus ulcer wounds, and 8 blisters and analyzed by biochemical techniques. The detection of wound infection was based on lysozyme and elastase triggered release of the dye from a peptidoglycan matrix. Incubation of 8% labeled agarose/peptidoglycan blend layers with infected wound fluid samples for two hours at 37 °C resulted in a four-fold higher amount of dye released than measured for noninfected wounds. Lysozyme activity in postoperative wounds and decubitus (bed sore) wound fluids was significantly elevated upon infection (4,830 ± 1,848 U/mL), compared to noninfected wounds (376 ± 240 U/mL).

A seven-fold higher amount of dye was released in case of infected wound fluid samples compared to noninfected ones using an alginate/peptidoglycan beads assay. By using Western blotting techniques, proteases including the gelatinase matrix metalloproteinases MMP-2 and MMP-9, and elastase were detected in wound fluids. A slight synergistic effect was measured by dye release for peptidoglycan hydrolysis, between lysozyme and these proteases. Incubation of a double-layer system consisting of stained and nonstained peptidoglycan with infected wound fluids resulted in a color change from yellow to blue, thus allowing simple visual detection of wound infection.

The authors concluded that such a diagnostic tool would allow early intervention with suitable treatment and could reduce clinical intervention and the use of antibiotics. The tool is based on human enzymes, which can be detected in wound fluid samples in a very fast way and which were shown to be elevated in case of infection. The study was published in September 2011, in the journal Diagnostic Microbiology and Infectious Disease.

Related Links:

Graz University of Technology





Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sample Transportation System
Tempus1800 Necto
Hemodynamic System Monitor
OptoMonitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.